Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Autoimmune Disorders

Free Subscription Articles published in J Clin Endocrinol Metab Retrieve available abstracts of 170 articles: HTML format

Single Articles

September 2025
1. VILLAGELIN D, Cooper DS
   Low Dose Methimazole in the Long-Term Management of Graves' Disease: Small doses, big benefits.
   J Clin Endocrinol Metab. 2025 Sep 10:dgaf503. doi: 10.1210.
   PubMed    
   
   
   August 2025
2. XU Y, Liu R, Huang L, Qin Y, et al
   Response to Letter to the Editor from Perros: Comprehensive Comparisons of Different Treatments for Active Graves Orbitopathy: A Systematic Review and Bayesian Model-Based Network Meta-Analysis.
   J Clin Endocrinol Metab. 2025 Aug 11:dgaf456. doi: 10.1210.
   PubMed    
   
   
   
3. PERROS P
   Letter to the Editor from Perros: Comprehensive Comparisons of Different Treatments for Active Graves' Orbitopathy: A Systematic Review and Bayesian Model-Based Network Meta-Analysis.
   J Clin Endocrinol Metab. 2025 Aug 11:dgaf455. doi: 10.1210.
   PubMed    
   
   
   
4. IGUDESMAN D, Nally LM, Grimshaw AA, Gunderson CG, et al
   Dietary patterns for weight and glycemic management in persons with type 1 diabetes: a meta-analysis of clinical trials.
   J Clin Endocrinol Metab. 2025 Aug 7:dgaf448. doi: 10.1210.
   PubMed     Abstract available
   
   
   
5. MIYAMURA K, Ito M, Yamaoka H, Hisakado M, et al
   Impact of minimal dose strategy before anti-thyroid drug discontinuation on relapse risk in Graves' disease.
   J Clin Endocrinol Metab. 2025 Aug 1:dgaf433. doi: 10.1210.
   PubMed     Abstract available
   
   
   
6. MYERS R, Yildiz M, Nuri Ozbek M, Manzoor J, et al
   Children with diabetes and at least one non-autoimmune feature should be considered for monogenic diabetes testing.
   J Clin Endocrinol Metab. 2025 Aug 1:dgaf430. doi: 10.1210.
   PubMed     Abstract available
   
   
   July 2025
7. NAKHLEH A, Robenshtok E, Adler L, Ben David SS, et al
   Clinical Characteristics and Outcomes of Graves' Disease in Individuals with Prior Hypothyroidism.
   J Clin Endocrinol Metab. 2025 Jul 25:dgaf426. doi: 10.1210.
   PubMed     Abstract available
   
   
   
8. KHORASHAD BS, Kaabi O, Gardner MD, Getahun D, et al
   Prevalence of Psychiatric Comorbidities in Females With Classic Congenital Adrenal Hyperplasia.
   J Clin Endocrinol Metab. 2025;110:e2562-e2569.
   PubMed     Abstract available
   
   
   
9. TILLMAN JB, Beck RW, Polonsky WH, Calhoun P, et al
   Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis.
   J Clin Endocrinol Metab. 2025;110:2134-2146.
   PubMed     Abstract available
   
   
   
10. WYCKOFF JA, Lapolla A, Asias-Dinh BD, Barbour LA, et al
    Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2025 Jul 13:dgaf288. doi: 10.1210.
    PubMed     Abstract available
    
    
    
11. AL NOFAL A, Benkhadra K, Abbas A, Nduwimana MJ, et al
    A Systematic Review Supporting the Clinical Practice Guidelines on the Management of Preexisting Diabetes and Pregnancy.
    J Clin Endocrinol Metab. 2025 Jul 13:dgaf289. doi: 10.1210.
    PubMed     Abstract available
    
    
    
12. MICHELS AW, Brusko TM, Evans-Molina C, Homann D, et al
    Challenges and Opportunities for Understanding the Pathogenesis of Type 1 Diabetes: An Endocrine Society Scientific Statement.
    J Clin Endocrinol Metab. 2025 Jul 9:dgaf267. doi: 10.1210.
    PubMed     Abstract available
    
    
    May 2025
13. KAEWKRASAESIN C, Hwang M, Vasandani C, Brown RJ, et al
    Clinical features, metabolic and autoimmune derangements in acquired partial lipodystrophy (Barraquer-Simons Syndrome).
    J Clin Endocrinol Metab. 2025 May 28:dgaf315. doi: 10.1210.
    PubMed     Abstract available
    
    
    
14. HAI Y, Ma Q, Fang S, Bahramimehr F, et al
    High-Throughput Proteomics and Immunohistochemistry of Orbital Connective Tissue in Graves' Orbitopathy.
    J Clin Endocrinol Metab. 2025 May 21:dgaf299. doi: 10.1210.
    PubMed     Abstract available
    
    
    
15. YIN Q, Zhu T, Song D, Fang S, et al
    Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED.
    J Clin Endocrinol Metab. 2025;110:1537-1549.
    PubMed     Abstract available
    
    
    
16. ZHANG Y, Alzahrani M, Luu T, Fatunbi J, et al
    Dyslipidemia is associated with increased NK cell cytotoxicity and autoimmunity in women with recurrent pregnancy losses.
    J Clin Endocrinol Metab. 2025 May 15:dgaf283. doi: 10.1210.
    PubMed     Abstract available
    
    
    April 2025
17. BUJNIS M, DeSalvo K, Neklason DW, Madsen MJ, et al
    Familial risk of Hashimoto's thyroiditis in a large genealogical database.
    J Clin Endocrinol Metab. 2025 Apr 28:dgaf251. doi: 10.1210.
    PubMed     Abstract available
    
    
    
18. HIRUMA S, Watanabe N, Noh JY, Hirose R, et al
    Occurrence of Newly Diagnosed Thyroid Cancer Is Not Increased After Radioactive Iodine Therapy for Graves' Disease.
    J Clin Endocrinol Metab. 2025 Apr 11:dgaf231. doi: 10.1210.
    PubMed     Abstract available
    
    
    
19. LEICHTER SB, Felton JL, Rasmussen CG, Rizzuto P, et al
    Establishing Screening Programs for Presymptomatic Type 1 Diabetes: Practical Guidance for Diabetes Care Providers.
    J Clin Endocrinol Metab. 2025 Apr 2:dgaf194. doi: 10.1210.
    PubMed     Abstract available
    
    
    March 2025
20. ONENGUT-GUMUSCU S, Concannon P, Akolkar B, Erlich HA, et al
    The Type 1 Diabetes Genetics Consortium (T1DGC).
    J Clin Endocrinol Metab. 2025 Mar 21:dgaf181. doi: 10.1210.
    PubMed     Abstract available
    
    
    
21. PETERS AL, Buzzetti R, Lee CJ, Pavo I, et al
    Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS.
    J Clin Endocrinol Metab. 2025;110:e962-e969.
    PubMed     Abstract available
    
    
    
22. KONDO T, Senokuchi T, Yano M, Takeda H, et al
    Benefits and Accuracy of Real-Time CGM in Children and Adolescents with Type 1 Diabetes Attending Summer Camp: 2nd year.
    J Clin Endocrinol Metab. 2025 Mar 12:dgaf160. doi: 10.1210.
    PubMed     Abstract available
    
    
    
23. NIERVES LA, Lin TT, Moradian A, Shen Q, et al
    Biomarkers, Proteoforms, and Mass Spectrometry-based Assays for Diabetes Clinical Research.
    J Clin Endocrinol Metab. 2025 Mar 8:dgaf159. doi: 10.1210.
    PubMed     Abstract available
    
    
    
24. MULLER NZ, Muresan IM, Kunzi A, Borojevic ZZ, et al
    Antibodies are predictive for diagnosis of celiac disease in pediatric type 1 diabetes.
    J Clin Endocrinol Metab. 2025 Mar 8:dgaf146. doi: 10.1210.
    PubMed     Abstract available
    
    
    
25. BERGMAN D, Kang X, Sun J, Ebrahimi F, et al
    Autoimmune Thyroid Diseases and Microscopic Colitis: A Nationwide Matched Case-Control Study in Sweden.
    J Clin Endocrinol Metab. 2025 Mar 5:dgaf140. doi: 10.1210.
    PubMed     Abstract available
    
    
    
26. GATTA E, Pirola I, Gotti A, Fredi M, et al
    Clinical phenotype of Graves' disease in Autoimmune Polyglandular Syndrome or as isolated disease: the GRAPHE study.
    J Clin Endocrinol Metab. 2025 Mar 1:dgaf144. doi: 10.1210.
    PubMed     Abstract available
    
    
    February 2025
27. HENSKE J, Turner LV, Riddell MC
    Approach to the Patient: Type 1 Diabetes Management with Exercise - Prepare, Perform, Stabilize, and Study.
    J Clin Endocrinol Metab. 2025 Feb 28:dgaf136. doi: 10.1210.
    PubMed     Abstract available
    
    
    
28. RAFI E, Tranchito L, Hatipoglu B
    Navigating Insulin Options for Diabetes Management.
    J Clin Endocrinol Metab. 2025;110.
    PubMed     Abstract available
    
    
    
29. LUNDGRIN EL, Kelly CA, Bellini N, Lewis C, et al
    Diabetes Technology Trends: A Review of the Latest Innovations.
    J Clin Endocrinol Metab. 2025;110.
    PubMed     Abstract available
    
    
    
30. GALDERISI A, Bonet J, Ismail HM, Moran A, et al
    Metabolic phenotype of Stage 1 and Stage 2 type 1 diabetes using modelling of beta cell function.
    J Clin Endocrinol Metab. 2025 Feb 24:dgaf086. doi: 10.1210.
    PubMed     Abstract available
    
    
    
31. HUMBERT L, Proust-Lemoine E, Dubucquoi S, Kemp EH, et al
    Lessons From Prospective Longitudinal Follow-up of a French APECED Cohort.
    J Clin Endocrinol Metab. 2025;110:e757-e773.
    PubMed     Abstract available
    
    
    
32. CAMOIN M, Mohammedi K, Saulnier PJ, Hadjadj S, et al
    Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC Population.
    J Clin Endocrinol Metab. 2025 Feb 4:dgae852. doi: 10.1210.
    PubMed     Abstract available
    
    
    January 2025
33. DIEDISHEIM M, Mallone R, Pugliese A, Dubois-Laforgue D, et al
    Insulitis and exocrinitis in autoantibody-positive non-diabetic individuals: role of HLA genotypes.
    J Clin Endocrinol Metab. 2025 Jan 28:dgaf039. doi: 10.1210.
    PubMed     Abstract available
    
    
    
34. SASO-JIMENEZ L, Urrutia I, Calvo B, Bilbao JR, et al
    Searching for monogenic autoimmune etiology in patients with type 1 diabetes onset under 30 months of age.
    J Clin Endocrinol Metab. 2025 Jan 28:dgaf049. doi: 10.1210.
    PubMed     Abstract available
    
    
    
35. SAARI V, Alanko V, Holopainen E, Makitie O, et al
    Progressive Impairment of Prepubertal Growth in Children With APECED.
    J Clin Endocrinol Metab. 2025;110:e257-e265.
    PubMed     Abstract available
    
    
    
36. LEWIS C, Rafi E, Dobbs B, Barton T, et al
    Tailoring Exercise Prescription for Effective Diabetes Glucose Management.
    J Clin Endocrinol Metab. 2025 Jan 21:dgae908. doi: 10.1210.
    PubMed     Abstract available
    
    
    
37. SHE R, Suvitaival T, Andersen HU, Hommel E, et al
    Metabolic Effects of Glucagon Stimulations in Type 1 Diabetes and Healthy Controls.
    J Clin Endocrinol Metab. 2025 Jan 20:dgaf030. doi: 10.1210.
    PubMed     Abstract available
    
    
    
38. ABU IRSHEED G, Steffen A, Martyn-Nemeth P, Park M, et al
    Multidimensional Sleep Health, Glycemic Control, and Self-Reported Outcomes in Type 1 Diabetes: A Cross-Sectional Study.
    J Clin Endocrinol Metab. 2025 Jan 16:dgaf032. doi: 10.1210.
    PubMed     Abstract available
    
    
    
39. JAHOOR F, Hsu JW, Keene KR, Peacock WF, et al
    Amino acids and CART distinguish A-beta+ Ketosis-Prone Diabetes from type 1 and type 2 diabetes during hyperglycemic crises.
    J Clin Endocrinol Metab. 2025 Jan 16:dgaf033. doi: 10.1210.
    PubMed     Abstract available
    
    
    
40. WANG S, Zhang Y, Balati A, Li B, et al
    Effect of Sodium-Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    J Clin Endocrinol Metab. 2025 Jan 15:dgaf016. doi: 10.1210.
    PubMed     Abstract available
    
    
    
41. GERA S, Rearson A, Baker G, Douvas JL, et al
    Changes in 90-Day Time in Range Among Youth with Type 1 Diabetes Initiating Different Automated Insulin Delivery Systems.
    J Clin Endocrinol Metab. 2025 Jan 15:dgaf006. doi: 10.1210.
    PubMed     Abstract available
    
    
    
42. KIM S, Subramanian S
    Approach to Lipid Management in the Patient with Diabetes.
    J Clin Endocrinol Metab. 2025 Jan 11:dgaf018. doi: 10.1210.
    PubMed     Abstract available
    
    
    
43. BARTALENA L, Smith TJ
    Treatment of Hyperthyroidism in Graves' Disease Complicated by Thyroid Eye Disease.
    J Clin Endocrinol Metab. 2025 Jan 9:dgaf009. doi: 10.1210.
    PubMed     Abstract available
    
    
    
44. DICKENS LT, Gonzalez MG
    Approach to the Patient using Diabetes Technology in Pregnancy.
    J Clin Endocrinol Metab. 2025 Jan 7:dgae914. doi: 10.1210.
    PubMed     Abstract available
    
    
    
45. AMENDOLARA R, D'Onofrio L, Sessa RL, Di Giulio S, et al
    IFN-alpha neutralizing antibodies distinguish LADA from early-onset type 1 diabetes.
    J Clin Endocrinol Metab. 2025 Jan 6:dgaf001. doi: 10.1210.
    PubMed     Abstract available
    
    
    
46. ORSOS I, Molnar Z, Ujhelyi B, Steiber Z, et al
    Stimulation of Piezo1 mechanosensitive channels inhibits adipogenesis in thyroid eye disease.
    J Clin Endocrinol Metab. 2025 Jan 2:dgae899. doi: 10.1210.
    PubMed     Abstract available
    
    
    December 2024
47. PENG R, Xie P, Jin Z, Zhou W, et al
    Significance of Thyroid Stimulating Immunoglobulin and Thyrotropin Receptor Antibody in Graves' Disease.
    J Clin Endocrinol Metab. 2024 Dec 23:dgae892. doi: 10.1210.
    PubMed     Abstract available
    
    
    
48. HUANG J, Su A, Yang J, Zhuang W, et al
    Postmarketing Safety Concerns of Teprotumumab: A Real-World Pharmacovigilance Assessment.
    J Clin Endocrinol Metab. 2024;110:159-165.
    PubMed     Abstract available
    
    
    
49. YU B, Wang Y, Jin J, Liu J, et al
    CD34+ orbital fibroblasts contribute to the pathogenesis of thyroid eye disease via miR-182-5p.
    J Clin Endocrinol Metab. 2024 Dec 18:dgae876. doi: 10.1210.
    PubMed     Abstract available
    
    
    
50. XU Y, Liu R, Huang L, Qin Y, et al
    Comprehensive Comparisons of Different Treatments for Active Graves' Orbitopathy: A Systematic Review and Bayesian Model-Based Network Meta-Analysis.
    J Clin Endocrinol Metab. 2024 Dec 16:dgae877. doi: 10.1210.
    PubMed     Abstract available
    
    
    
51. RAZVI SS, Wild H, Ingoe L, Vernazza J, et al
    Changes in thyroid function and autoimmunity in older individuals: longitudinal analysis of the Whickham cohort.
    J Clin Endocrinol Metab. 2024 Dec 14:dgae875. doi: 10.1210.
    PubMed     Abstract available
    
    
    
52. YOSHIMURA K, Hirota Y, Saito S, Nishikage S, et al
    Prediction of insulin requirements by explainable machine learning for individuals with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Dec 11:dgae863. doi: 10.1210.
    PubMed     Abstract available
    
    
    
53. FRANKS PW, Rich SS, Linder B, Zaghloul NA, et al
    A Research Roadmap to Address the Heterogeneity of Diabetes and Advance Precision Medicine.
    J Clin Endocrinol Metab. 2024 Dec 6:dgae844. doi: 10.1210.
    PubMed     Abstract available
    
    
    
54. LIN YK, Ye W, Hepworth E, Rickels MR, et al
    Impaired Awareness and Symptomatology of Hypoglycemia in Adults with Type 1 Diabetes using Continuous Glucose Monitoring.
    J Clin Endocrinol Metab. 2024 Dec 5:dgae846. doi: 10.1210.
    PubMed     Abstract available
    
    
    
55. GUO Y, Liu B, Liang W, Cheng Y, et al
    2'-O-Galloylhyperin Prevents Tissue Remodeling in Thyroid Eye Disease: Prospects as a Thyrotropin Receptor Antagonist.
    J Clin Endocrinol Metab. 2024 Dec 2:dgae732. doi: 10.1210.
    PubMed     Abstract available
    
    
    November 2024
56. WANG V, Walsh J, Zell J, Verrilli LE, et al
    Autoimmune Disease is Increased in Women with Primary Ovarian Insufficiency.
    J Clin Endocrinol Metab. 2024 Nov 28:dgae828. doi: 10.1210.
    PubMed     Abstract available
    
    
    
57. SMEW AI, Lundholm C, Gong T, Lichtenstein P, et al
    Glycaemic control and adult height: a nationwide Swedish cohort study on childhood type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Nov 18:dgae809. doi: 10.1210.
    PubMed     Abstract available
    
    
    
58. YARDLEY JE, Li Z, Zaharieva DP, Riddell MC, et al
    Sex Differences in Glycemia and Self-Management Strategies for Exercise in an Active Adults Cohort with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Nov 14:dgae792. doi: 10.1210.
    PubMed     Abstract available
    
    
    
59. WANG H, Li W, Chang P, Jia Q, et al
    Effect of methimazole withdrawl period on the I-131 uptake estimation using Tc-99m thyroid scanning in Graves' disease.
    J Clin Endocrinol Metab. 2024 Nov 11:dgae794. doi: 10.1210.
    PubMed     Abstract available
    
    
    
60. PHAM UN, Pryke A, Baskerville T, Griffin A, et al
    Kidney hyperfiltration and mitochondrial changes are associated with eGFR decline in young people with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Nov 11:dgae787. doi: 10.1210.
    PubMed     Abstract available
    
    
    October 2024
61. JOHNSON RJ, Bergford S, Gal RL, Calhoun P, et al
    The Role of Whole Food Plant-Based Food Intake on Postprandial Glycemia in Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Oct 18:dgae725. doi: 10.1210.
    PubMed     Abstract available
    
    
    
62. 
    Correction to: "Effects of Low-dose Methotrexate With Methimazole in Patients With Graves' Disease: Results of a Randomized Clinical Trial".
    J Clin Endocrinol Metab. 2024 Oct 16:dgae698. doi: 10.1210.
    PubMed    
    
    
    
63. HUBER E, Singh T, Bunk M, Hebel M, et al
    Discrimination and precision of Continuous Glucose Monitoring in staging children with presymptomatic type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Oct 16:dgae691. doi: 10.1210.
    PubMed     Abstract available
    
    
    
64. SUN A, Wang X, Qu J, Wu Y, et al
    The efficacy and safety of intravenous tocilizumab to treat Graves' ophthalmopathy: A systematic review and single-arm meta-analysis.
    J Clin Endocrinol Metab. 2024 Oct 14:dgae711. doi: 10.1210.
    PubMed     Abstract available
    
    
    
65. PHAM-DOBOR G, Kaltenecker P, Temesfoi V, Bajnok L, et al
    Systematic analysis and network mapping of disease associations in autoimmune polyglandular syndrome.
    J Clin Endocrinol Metab. 2024 Oct 8:dgae701. doi: 10.1210.
    PubMed     Abstract available
    
    
    September 2024
66. WEBER DR, O'Brien KO, Ballester L, Rackovsky N, et al
    Greater urinary calcium excretion is associated with diminished bone accrual in youth with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Sep 20:dgae660. doi: 10.1210.
    PubMed     Abstract available
    
    
    
67. FENG J, Xu X, Cai W, Yang X, et al
    Inhibiting Soluble Epoxide Hydrolase Suppresses NF-kappaB p65 Signaling and Reduces CXCL10 Expression as a Potential Therapeutic Target in Hashimoto's Thyroiditis.
    J Clin Endocrinol Metab. 2024;109:2579-2588.
    PubMed     Abstract available
    
    
    
68. XU L, Liu Z, Xu X, Wan Q, et al
    Thyroid autoimmunity is associated with dietary fat consumption.
    J Clin Endocrinol Metab. 2024 Sep 12:dgae629. doi: 10.1210.
    PubMed     Abstract available
    
    
    
69. WEBB-ROBERTSON BM, Wu W, Flores JE, Bramer LM, et al
    RNA Splicing Events in Circulation Distinguish Individuals with and without New-Onset Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Sep 10:dgae622. doi: 10.1210.
    PubMed     Abstract available
    
    
    
70. KARAKUS KE, Fleury T, Baschal EE, McDaniel KA, et al
    Clinical Features and HLA Genetics Differ in Children at Type 1 Diabetes Onset by Hispanic Ethnicity.
    J Clin Endocrinol Metab. 2024 Sep 4:dgae608. doi: 10.1210.
    PubMed     Abstract available
    
    
    August 2024
71. MOOIJ CF, Zwaveling-Soonawala N, Hillebrand JJ, van Trotsenburg ASP, et al
    Approach to the Patient: Challenging Cases of Pediatric Thyrotoxicosis.
    J Clin Endocrinol Metab. 2024 Aug 27:dgae592. doi: 10.1210.
    PubMed     Abstract available
    
    
    
72. ROMERES D, Ruchi FNU, Breton MD, Basu A, et al
    Post Prandial Glucose Turnover Differs Between Adolescents & Adults with Type 1 Diabetes: Triple Tracer Mixed Meal Study.
    J Clin Endocrinol Metab. 2024 Aug 22:dgae585. doi: 10.1210.
    PubMed     Abstract available
    
    
    
73. HAO L, Xue J
    Letter to the Editor from Hao and Xue: "Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-peptide Loss and Pancreatic Atrophy".
    J Clin Endocrinol Metab. 2024 Aug 16:dgae554. doi: 10.1210.
    PubMed    
    
    
    
74. SMITH TJ, Holt RJ, Fu Q, Qashqai A, et al
    Assessment of hearing dysfunction in patients with Graves' disease and thyroid eye disease without or with teprotumumab.
    J Clin Endocrinol Metab. 2024 Aug 14:dgae560. doi: 10.1210.
    PubMed     Abstract available
    
    
    
75. KAMIMOTO JLJ, Li Z, Gal RL, Castle JR, et al
    Effect of Impaired Awareness of Hypoglycemia on Glucose Decline During and After Exercise in the T1DEXI Study.
    J Clin Endocrinol Metab. 2024;109:2233-2241.
    PubMed     Abstract available
    
    
    
76. WU L, Carlino MS, Brown DA, Long GV, et al
    Response to Letter to the Editor from Hao and Xue: "Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-peptide Loss and Pancreatic Atrophy".
    J Clin Endocrinol Metab. 2024 Aug 13:dgae555. doi: 10.1210.
    PubMed    
    
    
    
77. ABU IRSHEED G, Martyn-Nemeth P, Baron KG, Reutrakul S, et al
    Sleep disturbances in type 1 diabetes and mitigating cardiovascular risk.
    J Clin Endocrinol Metab. 2024 Aug 6:dgae539. doi: 10.1210.
    PubMed     Abstract available
    
    
    
78. HE X, Cao L, Fu X, Wu Y, et al
    The association between telomere length and diabetes mellitus: accumulated evidence from observational studies.
    J Clin Endocrinol Metab. 2024 Aug 1:dgae536. doi: 10.1210.
    PubMed     Abstract available
    
    
    July 2024
79. ALVES JUNIOR JM, Bernardo W, Villagelin D
    "Effectiveness of Different Treatment Modalities in Initial and Chronic Phases of Thyroid Eye Disease: A Systematic Review with Meta-analysis".
    J Clin Endocrinol Metab. 2024 Jul 30:dgae526. doi: 10.1210.
    PubMed     Abstract available
    
    
    
80. ISMAIL HM, Perera D, Mandal R, DiMeglio LA, et al
    Gut microbial changes associated with obesity in youth with type 1 diabetes: a Pilot Study.
    J Clin Endocrinol Metab. 2024 Jul 30:dgae529. doi: 10.1210.
    PubMed     Abstract available
    
    
    
81. SHEN I, Usala RL, Mohseni M, Bouxsein ML, et al
    Adolescent girls with type 1 diabetes develop changes in bone prior to evidence of clinical neuropathy.
    J Clin Endocrinol Metab. 2024 Jul 26:dgae511. doi: 10.1210.
    PubMed     Abstract available
    
    
    
82. D'ADDIO F, Lazzaroni E, Lunati ME, Preziosi G, et al
    Vaccinome landscape in nearly 620,000 patients with diabetes.
    J Clin Endocrinol Metab. 2024 Jul 23:dgae476. doi: 10.1210.
    PubMed     Abstract available
    
    
    
83. LUPO MA, Olivo PD, Luffy M, Wolf J, et al
    US-based, Prospective, Blinded Study of Thyrotropin Receptor Antibody in Autoimmune Thyroid Disease.
    J Clin Endocrinol Metab. 2024 Jul 19:dgae448. doi: 10.1210.
    PubMed     Abstract available
    
    
    
84. ZHOU J, Chen W, Jiang WH, Wu Q, et al
    Altered Static and Dynamic Brain Functional Topological Organization in Patients With Dysthyroid Optic Neuropathy.
    J Clin Endocrinol Metab. 2024;109:2071-2082.
    PubMed     Abstract available
    
    
    
85. SIMS EK, Cuthbertson D, Jacobsen L, Ismail HM, et al
    Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals.
    J Clin Endocrinol Metab. 2024;109:2116-2123.
    PubMed     Abstract available
    
    
    
86. JONSDOTTIR B, Clasen JL, Vehik K, Lernmark A, et al
    Early appearance of thyroid autoimmunity in children followed from birth for type 1 diabetes risk.
    J Clin Endocrinol Metab. 2024 Jul 12:dgae478. doi: 10.1210.
    PubMed     Abstract available
    
    
    
87. XIE P, Shen L, Peng R, Wang Y, et al
    Effects of low-dose methotrexate with MMI in patients with Graves' disease: results of a randomized clinical trial.
    J Clin Endocrinol Metab. 2024 Jul 12:dgae472. doi: 10.1210.
    PubMed     Abstract available
    
    
    
88. AZIZI F, Mehran L, Abdi H, Amouzegar A, et al
    Approach to the Patient Considering Long-term Antithyroid Drug Therapy for Graves' Disease.
    J Clin Endocrinol Metab. 2024 Jul 9:dgae456. doi: 10.1210.
    PubMed     Abstract available
    
    
    
89. HORMAZABAL-AGUAYO I, Huerta-Uribe N, Munoz-Pardeza J, Ezzatvar Y, et al
    Association of physical activity patterns with nocturnal hypoglycemia events in youth with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Jul 2:dgae451. doi: 10.1210.
    PubMed     Abstract available
    
    
    June 2024
90. VITALE RJ, Tinsley LJ, Volkening LK, Laffel LM, et al
    Lower Independent Self-Care Readiness Persists over Time in Teens with Type 1 Diabetes and Executive Function Challenges.
    J Clin Endocrinol Metab. 2024 Jun 12:dgae391. doi: 10.1210.
    PubMed     Abstract available
    
    
    May 2024
91. MONTASER E, Farhy LS, Kovatchev BP
    Novel Detection and Progression Markers for Diabetes Based on Continuous Glucose Monitoring Data Dynamics.
    J Clin Endocrinol Metab. 2024 May 31:dgae379. doi: 10.1210.
    PubMed     Abstract available
    
    
    
92. XIE C, Huang W, Rayner CK, Horowitz M, et al
    Letter to the Editor From Xie et al: "The 13C Glucose Breath Test Accurately Identifies Insulin Resistance in People With Type 1 Diabetes".
    J Clin Endocrinol Metab. 2024 May 27:dgae366. doi: 10.1210.
    PubMed    
    
    
    
93. TRIOLO TM, Parikh HM, Tosur M, Ferrat L, et al
    Genetic Associations with C-peptide Levels before Type 1 Diabetes Diagnosis in At-Risk Relatives.
    J Clin Endocrinol Metab. 2024 May 20:dgae349. doi: 10.1210.
    PubMed     Abstract available
    
    
    
94. CONOVER CA, Bale LK, Stan MN
    PAPP-A as a Potential Target in Thyroid Eye Disease.
    J Clin Endocrinol Metab. 2024 May 16:dgae339. doi: 10.1210.
    PubMed     Abstract available
    
    
    
95. PRIBITZER S, O'Rourke C, Ylescupidez A, Smithmyer M, et al
    Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 May 7:dgae292. doi: 10.1210.
    PubMed     Abstract available
    
    
    April 2024
96. PETROVIC I, LoPresti J, Fatemi S, Gianoukakis A, et al
    Influence of Thyroglobulin (Tg) Autoantibodies on Tg levels Measured by Different Methodologies: (IMA, LC-MS/MS and RIA).
    J Clin Endocrinol Metab. 2024 Apr 30:dgae286. doi: 10.1210.
    PubMed     Abstract available
    
    
    
97. LING P, Yang D, Wang C, Zheng X, et al
    Basal Hyperglycemia Contributes More Than Fifty Percent to Time in Range in Pregnant Women with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Apr 30:dgae291. doi: 10.1210.
    PubMed     Abstract available
    
    
    
98. HAGELQVIST PG, Andersen A, Maytham K, Andreasen CR, et al
    Hemostatic Effects of Exercise-Related Hypoglycemia in Male Persons With Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Apr 20:dgae278. doi: 10.1210.
    PubMed     Abstract available
    
    
    
99. DU X, Zhu Y, Lu W, Fu N, et al
    Regulation of the Function of T Follicular Helper Cells and B Cells in Type 1 Diabetes Mellitus by the OX40/OX40L Axis.
    J Clin Endocrinol Metab. 2024 Apr 16:dgae248. doi: 10.1210.
    PubMed     Abstract available
    
    
    
100. BAEK HS, Kim J, Jeong C, Lee J, et al
     Deep Learning Analysis with Gray Scale and Doppler Ultrasonography Images to Differentiate Graves' Disease.
     J Clin Endocrinol Metab. 2024 Apr 13:dgae254. doi: 10.1210.
     PubMed     Abstract available
     
     
     
101. VILLAGELIN D, Cooper DS, Burch HB
     A 2023 International Survey of Clinical Practice Patterns in the Management of Graves' Disease: A Decade of Change.
     J Clin Endocrinol Metab. 2024 Apr 5:dgae222. doi: 10.1210.
     PubMed     Abstract available
     
     
     March 2024
102. MATSUO Y, Miyawaki A, Watanabe H, Matsui H, et al
     Potassium Iodide Use and Patient Outcomes for Thyroid Storm: An Observational Study.
     J Clin Endocrinol Metab. 2024 Mar 28:dgae187. doi: 10.1210.
     PubMed     Abstract available
     
     
     
103. THORNTON PS, De Leon DD, Empting S, Zangen D, et al
     Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children.
     J Clin Endocrinol Metab. 2024;109:1071-1079.
     PubMed     Abstract available
     
     
     
104. BROWN N, Elston MS
     Systematic Review-Type B Insulin Resistance With Isolated Hypoglycemia and Suppressed Insulin.
     J Clin Endocrinol Metab. 2024;109:936-943.
     PubMed     Abstract available
     
     
     
105. MERTENS J, Roosens L, Braspenning R, Vandebeeck J, et al
     The 13C glucose breath test accurately identifies insulin resistance in people with type 1 diabetes.
     J Clin Endocrinol Metab. 2024 Mar 15:dgae175. doi: 10.1210.
     PubMed     Abstract available
     
     
     
106. SOOY MGQ, Pyle L, Alonso GT, Broncucia HC, et al
     Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia.
     J Clin Endocrinol Metab. 2024 Mar 12:dgae158. doi: 10.1210.
     PubMed     Abstract available
     
     
     
107. DAYAN CM
     The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease).
     J Clin Endocrinol Metab. 2024 Mar 7:dgad693. doi: 10.1210.
     PubMed    
     
     
     February 2024
108. KIM KM, Kim KJ, Han K, Rhee Y, et al
     Associations Between Physical Activity and the Risk of Hip Fracture Depending on Glycemic Status: A Nationwide Cohort Study.
     J Clin Endocrinol Metab. 2024;109:e1194-e1203.
     PubMed     Abstract available
     
     
     
109. KONG YW, Yuan CY, Kiburg K, Brown K, et al
     Treatment satisfaction with Omnipod DASH in adults with type 1 diabetes: A non-blinded 1:1 randomized controlled trial.
     J Clin Endocrinol Metab. 2024 Feb 19:dgae088. doi: 10.1210.
     PubMed     Abstract available
     
     
     
110. LV Y, Lu X, Liu G, Qi L, et al
     Differential diagnosis of post pancreatitis diabetes mellitus based on pancreatic and gut hormone characteristics.
     J Clin Endocrinol Metab. 2024 Feb 12:dgae080. doi: 10.1210.
     PubMed     Abstract available
     
     
     
111. HELLEPUTTE S, Stautemas J, Jansseune L, De Backer T, et al
     Glycaemic management around postprandial exercise in people with type 1 diabetes: Challenge accepted.
     J Clin Endocrinol Metab. 2024 Feb 8:dgae079. doi: 10.1210.
     PubMed     Abstract available
     
     
     January 2024
112. MAKINO H, Tohyama M, Kawamura R, Takata Y, et al
     Fulminant type 1 diabetes caused by DIHS could be affected by the reactivation of HHV-6.
     J Clin Endocrinol Metab. 2024 Jan 31:dgae058. doi: 10.1210.
     PubMed     Abstract available
     
     
     
113. DOSIOU C
     "Teprotumumab for inactive thyroid eye disease? The jury is still out.".
     J Clin Endocrinol Metab. 2024 Jan 27:dgae052. doi: 10.1210.
     PubMed    
     
     
     
114. SHAH HS, McGill JB, Hirsch IB, Wu C, et al
     Poor glycemic control is associated with more rapid kidney function decline after the onset of diabetic kidney disease.
     J Clin Endocrinol Metab. 2024 Jan 23:dgae044. doi: 10.1210.
     PubMed     Abstract available
     
     
     
115. CLINCK I, Mertens J, Wouters K, Dirinck E, et al
     Insulin resistance and CGM-derived parameters in people with type 1 diabetes: are they associated?
     J Clin Endocrinol Metab. 2024 Jan 10:dgae015. doi: 10.1210.
     PubMed     Abstract available
     
     
     
116. ROMERES D, Yadav Y, Ruchi FNU, Carter R, et al
     Hyperglycemia suppresses Lactate Clearance during Exercise in Type 1 Diabetes.
     J Clin Endocrinol Metab. 2024 Jan 4:dgae005. doi: 10.1210.
     PubMed     Abstract available
     
     
     
117. 
     Correction to: "Ectopic Cervical Thymoma in a Patient Diagnosed With Graves Disease: A Systematic Literature Review".
     J Clin Endocrinol Metab. 2024 Jan 3:dgad759. doi: 10.1210.
     PubMed    
     
     
     December 2023
118. ZHANG Z, Luo S, Xiao Z, Yin W, et al
     Hsa_circRNA_405498 and hsa_circRNA_100033 serve as potential biomarkers for differential diagnosis of type 1 diabetes.
     J Clin Endocrinol Metab. 2023 Dec 29:dgad761. doi: 10.1210.
     PubMed     Abstract available
     
     
     
119. PEREA V, Vinagre I, Seres-Noriega T, Vinals C, et al
     Impact of preeclampsia and parity on sex-based discrepancies in subclinical carotid atherosclerosis in type 1 diabetes.
     J Clin Endocrinol Metab. 2023 Dec 27:dgad755. doi: 10.1210.
     PubMed     Abstract available
     
     
     
120. WEN X, Chang X, He X, Cai Q, et al
     Increased Thyroid DPP4 Expression is Associated with Inflammatory Process in Patients with Hashimoto's Thyroiditis.
     J Clin Endocrinol Metab. 2023 Dec 21:dgad723. doi: 10.1210.
     PubMed     Abstract available
     
     
     
121. ZHAO L, Li W, Liu L, Duan L, et al
     Clinical Features and Outcome Analysis of Type B Insulin Resistance Syndrome: A Single-Center Study in China.
     J Clin Endocrinol Metab. 2023;109:e175-e181.
     PubMed     Abstract available
     
     
     
122. OKSNES M, Husebye ES
     Approach to the Patient: Diagnosis of Primary Adrenal Insufficiency in Adults.
     J Clin Endocrinol Metab. 2023;109:269-278.
     PubMed    
     
     
     
123. PAPARODIS R, Livadas S, Karvounis E, Bantouna D, et al
     Elevated Preoperative TPO Ab Titers Decrease Risk for DTC in a Linear Fashion: A Retrospective Analysis of 1635 Cases.
     J Clin Endocrinol Metab. 2023;109:e347-e355.
     PubMed     Abstract available
     
     
     
124. TSAITLIN-MOR L, Cahen-Peretz A, Bentov Y, Ben-Shushan T, et al
     Long-Term Risk for Type 1 Diabetes and Obesity in Early Term Born Offspring: A Systematic Review and Meta-Analysis.
     J Clin Endocrinol Metab. 2023 Dec 11:dgad715. doi: 10.1210.
     PubMed     Abstract available
     
     
     
125. HOOPER AJ
     Letter to the Editor from Hooper: Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study".
     J Clin Endocrinol Metab. 2023 Dec 11:dgad719. doi: 10.1210.
     PubMed    
     
     
     
126. WU HX, Chu TY, Iqbal J, Jiang HL, et al
     Response to Letter to the Editor from Hooper: Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study.
     J Clin Endocrinol Metab. 2023 Dec 9:dgad720. doi: 10.1210.
     PubMed    
     
     
     November 2023
127. WU L, Carlino MS, Brown DA, Long GV, et al
     Checkpoint inhibitor associated autoimmune diabetes mellitus is characterised by C-peptide loss and pancreatic atrophy.
     J Clin Endocrinol Metab. 2023 Nov 24:dgad685. doi: 10.1210.
     PubMed     Abstract available
     
     
     
128. UHL S, Choure A, Rouse B, Loblack A, et al
     Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
     J Clin Endocrinol Metab. 2023 Nov 21:dgad652. doi: 10.1210.
     PubMed     Abstract available
     
     
     
129. LI P, Liu Y, Wei T, Wang X, et al
     Effect and interactions of BRAF on lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis.
     J Clin Endocrinol Metab. 2023 Nov 15:dgad667. doi: 10.1210.
     PubMed     Abstract available
     
     
     
130. LAFONTAINE N, Shore CJ, Campbell PJ, Mullin BH, et al
     Epigenome-wide association study shows differential DNA methylation of MDC1, KLF9 and CUTA in autoimmune thyroid disease.
     J Clin Endocrinol Metab. 2023 Nov 14:dgad659. doi: 10.1210.
     PubMed     Abstract available
     
     
     
131. MENON JC, Singh P, Archana A, Singh P, et al
     High frequency of recessive WFS1 mutations among Indian children with islet antibody-negative type 1 diabetes.
     J Clin Endocrinol Metab. 2023 Nov 1:dgad644. doi: 10.1210.
     PubMed     Abstract available
     
     
     October 2023
132. DOUGLAS RS, Couch S, Wester ST, Fowler BT, et al
     Efficacy and Safety of Teprotumumab in Thyroid Eye Disease Patients with Long Duration and Low Disease Activity.
     J Clin Endocrinol Metab. 2023 Oct 31:dgad637. doi: 10.1210.
     PubMed     Abstract available
     
     
     
133. NEMIROFF S, Chai R, Fan J, Ramer-Bass I, et al
     Ectopic Cervical Thymoma in a Patient Diagnosed with Graves Disease: A Systematic Literature Review.
     J Clin Endocrinol Metab. 2023 Oct 28:dgad635. doi: 10.1210.
     PubMed     Abstract available
     
     
     
134. WU Q, Zhou J, Fang W, Jiang WH, et al
     Structural and functional brain changes after glucocorticoid therapy in thyroid-associated ophthalmopathy.
     J Clin Endocrinol Metab. 2023 Oct 21:dgad626. doi: 10.1210.
     PubMed     Abstract available
     
     
     
135. BORCHERS J, Pukkala E, Makitie O, Laakso S, et al
     Epidemiology and Causes of Primary Adrenal Insufficiency in Children: A Population-Based Study.
     J Clin Endocrinol Metab. 2023;108:2879-2885.
     PubMed     Abstract available
     
     
     
136. LUI DTW, Wong CKH, Man KKC
     Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination'.
     J Clin Endocrinol Metab. 2023 Oct 17:dgad614. doi: 10.1210.
     PubMed    
     
     
     
137. MULLER I, Consonni D, Crivicich E, di Marco F, et al
     Response to Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination'.
     J Clin Endocrinol Metab. 2023 Oct 17:dgad616. doi: 10.1210.
     PubMed    
     
     
     
138. 
     Correction to "Autoimmune Diabetes From Chilhood to Adulthood: The Role of Pancreatic Autoantibodies and HLA-DRB1 Genotype".
     J Clin Endocrinol Metab. 2023 Oct 13:dgad609. doi: 10.1210.
     PubMed    
     
     
     
139. VAN'T WESTEINDE A, Padilla N, Fletcher-Sandersjoo S, Kampe O, et al
     Increased resting-state functional connectivity in patients with autoimmune Addison's disease.
     J Clin Endocrinol Metab. 2023 Oct 11:dgad592. doi: 10.1210.
     PubMed     Abstract available
     
     
     
140. 
     Correction to "Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study".
     J Clin Endocrinol Metab. 2023 Oct 11:dgad596. doi: 10.1210.
     PubMed    
     
     
     
141. GORSHTEIN A, Turjeman A, Duskin-Bitan H, Leibovici L, et al
     Graves' disease following COVID-19 vaccination: a population-based, matched case-control study.
     J Clin Endocrinol Metab. 2023 Oct 10:dgad582. doi: 10.1210.
     PubMed     Abstract available
     
     
     
142. ZHANG S, Zhao X, Wang X, Jin H, et al
     Gut microecology may be involved in pathogenesis of Hashimoto's thyroiditis by reducing production of hydrogen sulfide.
     J Clin Endocrinol Metab. 2023 Oct 4:dgad588. doi: 10.1210.
     PubMed     Abstract available
     
     
     
143. 
     Correction to: "OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody-Positive Individuals".
     J Clin Endocrinol Metab. 2023 Oct 4:dgad574. doi: 10.1210.
     PubMed    
     
     
     September 2023
144. NAESSEN S, Eliasson M, Berntorp K, Kitlinski M, et al
     Autoimmune disease in Turner syndrome in Sweden: An up to 25 years controlled follow-up study.
     J Clin Endocrinol Metab. 2023 Sep 27:dgad566. doi: 10.1210.
     PubMed     Abstract available
     
     
     
145. MELING STOKLAND AE, Austdal M, Nedrebo BG, Carlsen S, et al
     Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy.
     J Clin Endocrinol Metab. 2023 Sep 25:dgad538. doi: 10.1210.
     PubMed     Abstract available
     
     
     
146. XIAO WC, Li X, Shan R, Mei F, et al
     Pregnancy and progression of differentiated thyroid cancer: A propensity score-matched retrospective cohort study.
     J Clin Endocrinol Metab. 2023 Sep 20:dgad557. doi: 10.1210.
     PubMed     Abstract available
     
     
     
147. WANG M, Jiang X, Geng J, Hui S, et al
     Outcomes of Patients With Dysthyroid Optic Neuropathy Treated With Intravenous Corticosteroids and/or Orbital Decompression Surgery: A Systematic Review and Meta-analysis.
     J Clin Endocrinol Metab. 2023;108:2717-2727.
     PubMed     Abstract available
     
     
     
148. UELAND GA, Ueland HO, Stokland AM, Bhan A, et al
     Prevalence, risk factors, clinical and biochemical characteristics of Alemtuzumab-induced Graves' disease.
     J Clin Endocrinol Metab. 2023 Sep 14:dgad540. doi: 10.1210.
     PubMed     Abstract available
     
     
     
149. SOUTH AM, Rigdon J, Voruganti S, Stafford JM, et al
     Uric Acid is Not Associated with Cardiovascular Health in Youth with Type 1 Diabetes: SEARCH for Diabetes in Youth Study.
     J Clin Endocrinol Metab. 2023 Sep 10:dgad534. doi: 10.1210.
     PubMed     Abstract available
     
     
     
150. RAMZY A, Saber N, Bruin JE, Thompson DM, et al
     Thyroid hormone levels correlate with the maturation of implanted pancreatic endoderm cells in patients with type 1 diabetes.
     J Clin Endocrinol Metab. 2023 Sep 6:dgad499. doi: 10.1210.
     PubMed     Abstract available
     
     
     August 2023
151. FU J, Guan H
     The Impact of Salt Iodization on the Occurrence of Hyperthyroidism: Evidence from General Populations to Pregnant Women.
     J Clin Endocrinol Metab. 2023 Aug 31:dgad522. doi: 10.1210.
     PubMed    
     
     
     
152. MULLER I, Consonni D, Crivicich E, Di Marco F, et al
     Increased risk of Thyroid Eye Disease following Covid-19 Vaccination.
     J Clin Endocrinol Metab. 2023 Aug 25:dgad501. doi: 10.1210.
     PubMed     Abstract available
     
     
     
153. HITT TA, Hannon TS, Magge SN
     Approach to the Patient with Youth-Onset Type 2 Diabetes.
     J Clin Endocrinol Metab. 2023 Aug 16:dgad482. doi: 10.1210.
     PubMed     Abstract available
     
     
     
154. PARK J, Ntelis S, Yunasan E, Downton KD, et al
     Glucagon-like peptide 1 Analogues as Adjunctive Therapy for Patients with Type 1 Diabetes: an Updated Systematic Review and Meta-analysis.
     J Clin Endocrinol Metab. 2023 Aug 10:dgad471. doi: 10.1210.
     PubMed     Abstract available
     
     
     
155. BILLINGS LK, Shi Z, Wei J, Rifkin AS, et al
     Utility of polygenic scores for differentiating diabetes diagnosis among patients with atypical phenotypes of diabetes.
     J Clin Endocrinol Metab. 2023 Aug 10:dgad456. doi: 10.1210.
     PubMed     Abstract available
     
     
     
156. FISKER FA, Voss TS, Svart MV, Kampmann U, et al
     Insulin signaling is preserved in skeletal muscle during early diabetic ketoacidosis.
     J Clin Endocrinol Metab. 2023 Aug 9:dgad464. doi: 10.1210.
     PubMed     Abstract available
     
     
     
157. BELLINI S, Guarrera S, Matullo G, Schalkwijk C, et al
     Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: the EURODIAB Prospective Complications Study.
     J Clin Endocrinol Metab. 2023 Aug 8:dgad468. doi: 10.1210.
     PubMed     Abstract available
     
     
     July 2023
158. ETTINGER RA, Buitinga M, Vandamme C, Afonso G, et al
     Technical Validation and Utility of an HLA Class II Tetramer Assay for Type 1 Diabetes: A Multicenter Study.
     J Clin Endocrinol Metab. 2023 Jul 20:dgad434. doi: 10.1210.
     PubMed     Abstract available
     
     
     
159. HARTMANN B, Longo M, Mathiesen DS, Hare KJ, et al
     Signs of a Glucose and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes.
     J Clin Endocrinol Metab. 2023 Jul 19:dgad431. doi: 10.1210.
     PubMed     Abstract available
     
     
     
160. KRISTENSEN KB, Ranjan AG, McCarthy OM, Holst JJ, et al
     Effects of a low-carbohydrate-high-protein pre-exercise meal in type 1 diabetes - a randomised, crossover trial.
     J Clin Endocrinol Metab. 2023 Jul 18:dgad427. doi: 10.1210.
     PubMed     Abstract available
     
     
     June 2023
161. KAHALY GJ, Dolman PJ, Wolf J, Giers BC, et al
     Proof-of-Concept and Randomized, Placebo-Controlled Trials of an Fcrn Inhibitor, Batoclimab, for Thyroid Eye Disease.
     J Clin Endocrinol Metab. 2023 Jun 30:dgad381. doi: 10.1210.
     PubMed     Abstract available
     
     
     
162. WANG Q, Chen Y, Xie Y, Xia Y, et al
     Type 2 diabetes family history as a significant index on the clinical heterogeneity differentiation in type 1 diabetes.
     J Clin Endocrinol Metab. 2023 Jun 15:dgad363. doi: 10.1210.
     PubMed     Abstract available
     
     
     
163. IMAGAWA A, Hanafusa T
     Fulminant type 1 diabetes - East and West.
     J Clin Endocrinol Metab. 2023 Jun 13:dgad329. doi: 10.1210.
     PubMed     Abstract available
     
     
     
164. SIMMONS KM, Sims EK
     Screening and prevention of type 1 diabetes: Where are we?
     J Clin Endocrinol Metab. 2023 Jun 8:dgad328. doi: 10.1210.
     PubMed     Abstract available
     
     
     May 2023
165. GIANDALIA A, Russo GT, Ruggeri P, Giancaterini A, et al
     The burden of obesity in type 1 diabetic subjects: a sex-specific analysis from the AMD Annals Initiative.
     J Clin Endocrinol Metab. 2023 May 29:dgad302. doi: 10.1210.
     PubMed     Abstract available
     
     
     
166. ELEFTHERIOU A, Ong KK, Hughes IA, Petry CJ, et al
     Leptin and IGF-1 in infancy are associated with variants in DHCR7 and CYP2R1 that relate with type 1 diabetes and 25OHD.
     J Clin Endocrinol Metab. 2023 May 12:dgad263. doi: 10.1210.
     PubMed     Abstract available
     
     
     
167. VERHOEFF K, Marfil-Garza BA, Czarnecka Z, Cuesta-Gomez N, et al
     Stem Cell-Derived Islet Transplantation in Patients with Type 2 Diabetes: Can Diabetes Subtypes Guide Implementation?
     J Clin Endocrinol Metab. 2023 May 12:dgad257. doi: 10.1210.
     PubMed     Abstract available
     
     
     April 2023
168. WU HX, Chu TY, Iqbal J, Jiang HL, et al
     Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study.
     J Clin Endocrinol Metab. 2023 Apr 24:dgad233. doi: 10.1210.
     PubMed     Abstract available
     
     
     
169. DERELLA CC, Thomas J, Harris RA
     Women Have Greater Endothelin-B Receptor Function and Lower Mitochondrial Capacity Compared to Men with Type 1 Diabetes.
     J Clin Endocrinol Metab. 2023 Apr 3:dgad189. doi: 10.1210.
     PubMed     Abstract available
     
     
     March 2023
170. WRIGHT JJ, Dulaney A, Williams JM, Hilmes MA, et al
     Longitudinal MRI Shows Progressive Decline in Pancreas Size and Altered Pancreas Shape in Type 1 Diabetes.
     J Clin Endocrinol Metab. 2023 Mar 20:dgad150. doi: 10.1210.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.